Search clinical trials for: Phase IIa

Total 19269 results

National Center for Complementary and Integrative...

Completed

Chromium Picolinate for the Treatment of Metabolic Syndrome

Metabolic Diseases | Obesity | Insulin Resistance | Prediabetic State | Metabolic Syndrome X

United States
National Center for Complementary and Integrative...
National Cancer Institute (NCI); National Institute of Allergy and Infectious...

Completed

Developmental Study on Fatigue in Cancer

Neoplasms

United States
Abbott

Terminated

Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness

Bipolar Disorder

United States
Abbott

Completed

Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis

End Stage Renal Disease | Secondary Hyperparathyroidism

United States
Abbott

Terminated

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

End-Stage Kidney Disease

United States
Laboratoires Thea

Completed

Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis

Keratoconjunctivitis, Vernal
Laboratoires Thea

Completed

Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome

Dry Eye Syndromes
General Hospital Sveti Duh

Completed

Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial

End Stage Renal Disease | Renal Anemia | Regular Dialysis Treatment

Croatia
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Urologic Neoplasms

Finland, France, Germany
Eli Lilly and Company

Completed

A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis

Sepsis

United States, Poland, Belgium, Netherlands, Hungary
Eli Lilly and Company

Completed

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

Pancreatic Neoplasms | Metastases, Neoplasm

United States, France, United Kingdom, Germany, Taiwan, Spain, Belgium, Portugal, Peru, Austria, Italy, Sweden, Netherlands, Venezuela, Argentina, Australia, Colombia, Greece
Eli Lilly and Company

Completed

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Carcinoma, Non-Small-Cell Lung | Neoplasms, Lung | Pulmonary Neoplasms

United States
Eli Lilly and Company

Completed

ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Urologic Neoplasms | Metastases, Neoplasm

United States
Eli Lilly and Company

Completed

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, France, Germany, Taiwan, Spain, Belgium, Switzerland, Netherlands, Russian Federation, South Africa, Poland, Hungary, Italy, Norway, India, Sweden, Argentina, United Kingdom, Puerto Rico, Chile, Romania
Eli Lilly and Company

Completed

A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.

Breast Neoplasms

United States
Eli Lilly and Company

Completed

Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

Breast Neoplasms

United States, Argentina, Chile, India, Mexico
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.

Colorectal Cancer

United States
Eli Lilly and Company

Completed

A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury

Acute Lung Injury | Respiratory Distress Syndrome, Adult

United States, Belgium, Spain, Canada, Australia, New Zealand
National Cancer Institute (NCI)

Completed

A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors

Neoplasms | Lymphoma

United States
Acusphere

Completed

Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography

Coronary Artery Disease

United States
Acusphere

Completed

Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging

Coronary Artery Disease

United States
Foundation for Liver Research
Kyowa Kirin Co., Ltd.

Completed

Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection

Chronic Hepatitis C

Netherlands
SK Chemicals Co., Ltd.

Terminated

Phase II Trial of SK3530 in Erectile Dysfunction

Male Erectile Dysfunction
Regional Hospital Holstebro

Completed

Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis

Liver Cirrhosis
Sheba Medical Center

Unknown

Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) Kit

Multiple Sclerosis | Balance | Cerebelar Impairment

Israel
Central European Leukemia Study Group

Unknown

Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase

Chronic Myeloid Leukemia

Austria
Central Jutland Regional Hospital

Unknown

The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.

Infertility

Denmark
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Completed

Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis

Histoplasmosis | Sporotrichosis | Blastomycosis
National Institute of Allergy and Infectious Diseases...
University of Alabama at Birmingham

Completed

Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis

Sporotrichosis
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Completed

Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis

Histoplasmosis | Sporotrichosis | Blastomycosis
Association Pour La Recherche des Thérapeutiques...

Unknown

Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen

Breast Neoplasms | Chemotherapy

France
Royal Marsden NHS Foundation Trust

Completed

A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma

Multiple Myeloma

United Kingdom
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome

Lung Diseases | Acute Respiratory Distress Syndrome
Université de Montréal
Gambro Renal Products, Inc.

Completed

Hemocontrol and Blood Pressure Control in Dialysis Patients

Hemodialysis | End-Stage Renal Disease

Canada
Hokkaido Gastrointestinal Cancer Study Group

Completed

Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

Gastric Cancer
Celgene Corporation
Prologue Research International

Terminated

Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Ovarian Cancer

United States
North Eastern German Society of Gynaecological...

Completed

Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy

Ovarian Cancer

Germany
Halozyme Therapeutics

Completed

A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects

Healthy

United States
Tel-Aviv Sourasky Medical Center

Unknown

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

Colon Neoplasm
OSI Pharmaceuticals

Completed

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Gastric Adenocarcinoma | Gastroesophageal Adenocarcinoma

United States, United Kingdom, Belgium
Federal University of São Paulo

Unknown

Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis

Peritoneal Dialysis | Renal Failure, End Stage

Brazil
Genta Incorporated

Completed

Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma | Refractory Lymphoma | Relapsed Lymphoma | Low-Grade Lymphoma | Intermediate-Grade Lymphoma

United States
Hokkaido Gastrointestinal Cancer Study Group

Suspended

Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

Gastric Cancer

Japan
Hamilton Health Sciences Corporation
St. Joseph's Healthcare Hamilton

Unknown

Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population

Bleeding | End Stage Renal Disease

Canada
West Japan Thoracic Oncology Group

Unknown

Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

Lung Cancer

Japan
West Japan Thoracic Oncology Group

Completed

Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Lung Cancer
West Japan Thoracic Oncology Group

Completed

A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer

Lung Cancer
National Taiwan University Hospital

Unknown

The Study of Human Atherosclerosis by Polarization-Sensitive Optical Coherence Tomography

Pathological Conditions, Anatomical

Taiwan
National Taiwan University Hospital

Unknown

Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis

End-Stage Renal Disease

Taiwan

3

Subscribe